- Home
- NRXS vs SACH Comparison
NRXS vs SACH Comparison
Compare NRXS & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXS | SACH |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7M | 47.5M |
| IPO Year | 2023 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NRXS | SACH |
|---|---|---|
| Price | $4.46 | $1.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $8.00 | $2.00 |
| AVG Volume (30 Days) | ★ 899.5K | 294.0K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,362,320.00 | ★ $3,906,000.00 |
| Revenue This Year | $31.05 | N/A |
| Revenue Next Year | $137.61 | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.89 | N/A |
| 52 Week Low | $1.33 | $0.80 |
| 52 Week High | $6.20 | $1.40 |
Technical Indicators
Market Signals| Indicator | NRXS | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 76.30 | 50.26 |
| Support Level | $2.63 | $1.03 |
| Resistance Level | $4.70 | $1.13 |
| Average True Range (ATR) | 0.40 | 0.05 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 92.75 | 26.05 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.